Enhanced control of oncolytic measles virus using microRNA target sites
Measles viruses derived from the live-attenuated Edmonton-B vaccine lineage are currently investigated as novel anti-cancer therapeutics. In this context, tumor specificity and oncolytic potency are key determinants of the therapeutic index. Here, we describe a systematic and comprehensive analysis...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
12 April 2018
|
| In: |
Molecular therapy. Oncolytics
Year: 2018, Jahrgang: 9, Pages: 30-40 |
| ISSN: | 2372-7705 |
| DOI: | 10.1016/j.omto.2018.04.002 |
| Online-Zugang: | Verlag, Volltext: https://doi.org/10.1016/j.omto.2018.04.002 Verlag: http://www.sciencedirect.com/science/article/pii/S2372770518300093 
|
| Verfasserangaben: | Mathias Felix Leber, Marc-Andrea Baertsch, Sophie Caroline Anker, Luisa Henkel, Hans Martin Singh, Sascha Bossow, Christine E. Engeland, Russell Barkley, Birgit Hoyler, Jessica Albert, Christoph Springfeld, Dirk Jäger, Christof von Kalle, and Guy Ungerechts |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1690908297 | ||
| 003 | DE-627 | ||
| 005 | 20220818000216.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200225s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.omto.2018.04.002 |2 doi | |
| 035 | |a (DE-627)1690908297 | ||
| 035 | |a (DE-599)KXP1690908297 | ||
| 035 | |a (OCoLC)1341308062 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Leber, Mathias Felix |d 1985- |e VerfasserIn |0 (DE-588)1057902306 |0 (DE-627)795388780 |0 (DE-576)413908348 |4 aut | |
| 245 | 1 | 0 | |a Enhanced control of oncolytic measles virus using microRNA target sites |c Mathias Felix Leber, Marc-Andrea Baertsch, Sophie Caroline Anker, Luisa Henkel, Hans Martin Singh, Sascha Bossow, Christine E. Engeland, Russell Barkley, Birgit Hoyler, Jessica Albert, Christoph Springfeld, Dirk Jäger, Christof von Kalle, and Guy Ungerechts |
| 264 | 1 | |c 12 April 2018 | |
| 300 | |a 11 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 25.02.2020 | ||
| 520 | |a Measles viruses derived from the live-attenuated Edmonton-B vaccine lineage are currently investigated as novel anti-cancer therapeutics. In this context, tumor specificity and oncolytic potency are key determinants of the therapeutic index. Here, we describe a systematic and comprehensive analysis of a recently developed post-entry targeting strategy based on the incorporation of microRNA target sites (miRTS) into the measles virus genome. We have established viruses with target sites for different microRNA species in the 3′ untranslated regions of either the N, F, H, or L genes and generated viruses harboring microRNA target sites in multiple genes. We report critical importance of target-site positioning with proximal genomic positions effecting maximum vector control. No relevant additional effect of six versus three miRTS copies for the same microRNA species in terms of regulatory efficiency was observed. Moreover, we demonstrate that, depending on the microRNA species, viral mRNAs containing microRNA target sites are directly cleaved and/or translationally repressed in presence of cognate microRNAs. In conclusion, we report highly efficient control of measles virus replication with various miRTS positions for development of safe and efficient cancer virotherapy and provide insights into the mechanisms underlying microRNA-mediated vector control. | ||
| 650 | 4 | |a measles virus | |
| 650 | 4 | |a microRNA target sites | |
| 650 | 4 | |a microRNAs | |
| 650 | 4 | |a oncolytic viruses | |
| 650 | 4 | |a post-entry targeting | |
| 650 | 4 | |a vector engineering | |
| 650 | 4 | |a vector safety | |
| 700 | 1 | |a Bärtsch, Marc-Andrea |d 1988- |e VerfasserIn |0 (DE-588)1099464854 |0 (DE-627)858599074 |0 (DE-576)469306505 |4 aut | |
| 700 | 1 | |a Anker, Sophie |d 1990- |e VerfasserIn |0 (DE-588)1205326065 |0 (DE-627)169090965X |4 aut | |
| 700 | 1 | |a Singh, Hans Martin |d 1986- |e VerfasserIn |0 (DE-588)1077055021 |0 (DE-627)835896986 |0 (DE-576)445904542 |4 aut | |
| 700 | 1 | |a Bossow, Sascha |e VerfasserIn |0 (DE-588)1051960525 |0 (DE-627)787207772 |0 (DE-576)40761852X |4 aut | |
| 700 | 1 | |a Engeland, Christine Elisabeth |d 1985- |e VerfasserIn |0 (DE-588)1025405951 |0 (DE-627)722221193 |0 (DE-576)370314670 |4 aut | |
| 700 | 1 | |a Springfeld, Christoph |d 1972- |e VerfasserIn |0 (DE-588)123388910 |0 (DE-627)706281039 |0 (DE-576)293689385 |4 aut | |
| 700 | 1 | |a Jäger, Dirk |d 1964- |e VerfasserIn |0 (DE-588)1032507535 |0 (DE-627)738505323 |0 (DE-576)380074125 |4 aut | |
| 700 | 1 | |a Kalle, Christof von |d 1962- |e VerfasserIn |0 (DE-588)1036481115 |0 (DE-627)75107926X |0 (DE-576)168957396 |4 aut | |
| 700 | 1 | |a Ungerechts, Guy |d 1972- |e VerfasserIn |0 (DE-588)124557902 |0 (DE-627)363420053 |0 (DE-576)294230939 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Molecular therapy. Oncolytics |d Cambridge, MA : Cell Press, 2014 |g 9(2018), Seite 30-40 |h Online-Ressource |w (DE-627)843857420 |w (DE-600)2842549-2 |w (DE-576)453321577 |x 2372-7705 |7 nnas |a Enhanced control of oncolytic measles virus using microRNA target sites |
| 773 | 1 | 8 | |g volume:9 |g year:2018 |g pages:30-40 |g extent:11 |a Enhanced control of oncolytic measles virus using microRNA target sites |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.omto.2018.04.002 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u http://www.sciencedirect.com/science/article/pii/S2372770518300093 |x Verlag |
| 951 | |a AR | ||
| 992 | |a 20200225 | ||
| 993 | |a Article | ||
| 994 | |a 2018 | ||
| 998 | |g 124557902 |a Ungerechts, Guy |m 124557902:Ungerechts, Guy |d 910000 |d 910100 |e 910000PU124557902 |e 910100PU124557902 |k 0/910000/ |k 1/910000/910100/ |p 14 |y j | ||
| 998 | |g 1036481115 |a Kalle, Christof von |m 1036481115:Kalle, Christof von |d 910000 |e 910000PK1036481115 |k 0/910000/ |p 13 | ||
| 998 | |g 1032507535 |a Jäger, Dirk |m 1032507535:Jäger, Dirk |d 910000 |e 910000PJ1032507535 |k 0/910000/ |p 12 | ||
| 998 | |g 123388910 |a Springfeld, Christoph |m 123388910:Springfeld, Christoph |d 910000 |d 910100 |e 910000PS123388910 |e 910100PS123388910 |k 0/910000/ |k 1/910000/910100/ |p 11 | ||
| 998 | |g 1025405951 |a Engeland, Christine Elisabeth |m 1025405951:Engeland, Christine Elisabeth |d 910000 |d 910100 |e 910000PE1025405951 |e 910100PE1025405951 |k 0/910000/ |k 1/910000/910100/ |p 7 | ||
| 998 | |g 1051960525 |a Bossow, Sascha |m 1051960525:Bossow, Sascha |d 50000 |e 50000PB1051960525 |k 0/50000/ |p 6 | ||
| 998 | |g 1077055021 |a Singh, Hans Martin |m 1077055021:Singh, Hans Martin |d 910000 |d 910100 |e 910000PS1077055021 |e 910100PS1077055021 |k 0/910000/ |k 1/910000/910100/ |p 5 | ||
| 998 | |g 1205326065 |a Anker, Sophie |m 1205326065:Anker, Sophie |d 910000 |d 910100 |e 910000PA1205326065 |e 910100PA1205326065 |k 0/910000/ |k 1/910000/910100/ |p 3 | ||
| 998 | |g 1099464854 |a Bärtsch, Marc-Andrea |m 1099464854:Bärtsch, Marc-Andrea |d 910000 |d 910100 |e 910000PB1099464854 |e 910100PB1099464854 |k 0/910000/ |k 1/910000/910100/ |p 2 | ||
| 998 | |g 1057902306 |a Leber, Mathias Felix |m 1057902306:Leber, Mathias Felix |p 1 |x j | ||
| 999 | |a KXP-PPN1690908297 |e 3598138784 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"title":[{"title_sort":"Enhanced control of oncolytic measles virus using microRNA target sites","title":"Enhanced control of oncolytic measles virus using microRNA target sites"}],"note":["Gesehen am 25.02.2020"],"origin":[{"dateIssuedDisp":"12 April 2018","dateIssuedKey":"2018"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"relHost":[{"title":[{"title_sort":"Molecular therapy","partname":"Oncolytics","title":"Molecular therapy"}],"pubHistory":["Volume 1 (2014)-volume 31 (2023)"],"origin":[{"dateIssuedDisp":"2017-","publisher":"Cell Press ; Nature Publishing Group","dateIssuedKey":"2017","publisherPlace":"Cambridge, MA ; London"}],"note":["Gesehen am 19.09.2024"],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Enhanced control of oncolytic measles virus using microRNA target sitesMolecular therapy. Oncolytics","recId":"843857420","physDesc":[{"extent":"Online-Ressource"}],"name":{"displayForm":["American Society of Gene & Cell Therapy"]},"id":{"eki":["843857420"],"issn":["2372-7705"],"zdb":["2842549-2"]},"corporate":[{"role":"isb","display":"American Society of Gene & Cell Therapy"}],"language":["eng"],"part":{"text":"9(2018), Seite 30-40","extent":"11","volume":"9","year":"2018","pages":"30-40"}}],"recId":"1690908297","physDesc":[{"extent":"11 S."}],"name":{"displayForm":["Mathias Felix Leber, Marc-Andrea Baertsch, Sophie Caroline Anker, Luisa Henkel, Hans Martin Singh, Sascha Bossow, Christine E. Engeland, Russell Barkley, Birgit Hoyler, Jessica Albert, Christoph Springfeld, Dirk Jäger, Christof von Kalle, and Guy Ungerechts"]},"id":{"eki":["1690908297"],"doi":["10.1016/j.omto.2018.04.002"]},"person":[{"given":"Mathias Felix","role":"aut","display":"Leber, Mathias Felix","family":"Leber"},{"role":"aut","given":"Marc-Andrea","family":"Bärtsch","display":"Bärtsch, Marc-Andrea"},{"display":"Anker, Sophie","family":"Anker","given":"Sophie","role":"aut"},{"given":"Hans Martin","role":"aut","display":"Singh, Hans Martin","family":"Singh"},{"given":"Sascha","role":"aut","display":"Bossow, Sascha","family":"Bossow"},{"role":"aut","given":"Christine Elisabeth","family":"Engeland","display":"Engeland, Christine Elisabeth"},{"display":"Springfeld, Christoph","family":"Springfeld","given":"Christoph","role":"aut"},{"given":"Dirk","role":"aut","display":"Jäger, Dirk","family":"Jäger"},{"given":"Christof von","role":"aut","display":"Kalle, Christof von","family":"Kalle"},{"display":"Ungerechts, Guy","family":"Ungerechts","given":"Guy","role":"aut"}],"language":["eng"]} | ||
| SRT | |a LEBERMATHIENHANCEDCO1220 | ||